Managed Care Contracts
Managed care is a health care delivery system organized to manage cost, utilization, and quality. Every healthcare provider must settle on a managed care contract between itself and the payer.
According to Findlaw.com, the contract between a clinical laboratory or other health care professional and a managed care organization (MCO) such as a provider-sponsored network, integrated delivery system, health maintenance organization, or other health care plan, is the fundamental document which frames, defines and governs their relationship. Contractual provisions can affect payment, office organization, practices and procedures, and confidential records as well as clinical decision-making.
Findlaw states, “A good managed care contract, like any other form of business agreement, is clear, consistent, comprehensive, and concise. It will conform to both the intent of the parties, setting out their respective rights and responsibilities, and the requirements of state and federal law.”
For example, Medicaid managed care provides for the delivery of Medicaid health benefits and additional services through contracted arrangements between state Medicaid agencies and managed care organizations (MCOs) that accept a set per member per month (capitation) payment for these services.
Depending on the market share of the health plan and the services offered by the healthcare provider, the negotiability of the contract will vary. Well-established managed care plans that have a large market share typical use form contracts. Newer managed care plans that have little market share and want broad provider participation are generally more willing to negotiate terms.
The Patient Protection and Affordable Care Act and the move toward accountable care has put a much greater emphasis on quality measures than in previous years.
Healthcare providers must prove in contract negotiations how well they manage quality and cost; such proof is usually provided with a comprehensive set of quality measures reported directly from the electronic health record (EHR). This can be straightforward for a single practice using the basic reporting functionality of its EHR, a more complex managed care plan might require features that an EHR vendor doesn’t offer.
Labs Should Build Payer Relationships to Improve Commodity Pricing
By Robert Michel | From the Volume XXXI, Number 1 – January 16, 2024 Issue
“Health plans are interested in improving outcomes and saving money on complex, expensive cases because that’s where the money is. At the same time, that’s an opportunity for labs to help health plans cut costs while also improving quality. ” —Kerry Kaplan, Presi…
Exclusive Lab Contracts Have Consequences
By Robert Michel | From the Volume XXXI, Number 1 – January 16, 2024 Issue
CEO SUMMARY: During the past seven months, competition in the Northeast has intensified. Decisions by UnitedHealth and Aetna to exclude a national laboratory from their respective provider panels has forced many physicians to reconsider their choice of laboratory provider—creating an op…
Quest Wants It Both Ways with Payer Contracts
By Robert Michel | From the Volume XXXI, Number 1 – January 16, 2024 Issue
CEO SUMMARY: Once again, public laboratory companies are pursuing short-term strategies that promise competitive advantage to themselves. But these strategies also carry long term risks that could burden the entire laboratory industry. Contradictions in the current cycle of competition fo…
Labs Can Be Misguided by Pull-Through Test Myth
By Robert Michel | From the Volume XXXI, Number 1 – January 16, 2024 Issue
CEO SUMMARY: For the first time in almost eight years, there are major disruptions to the status quo in managed care contracting for laboratory testing services. As was true in the 1990s, national lab companies are pursuing exclusive national contracts with the nation’s…
Aetna Says: LabCorp Is Out & Quest Diagnostics Is In
By Robert Michel | From the Volume XXXI, Number 1 – January 16, 2024 Issue
CEO SUMMARY: January 1, 2007 can be considered the start of a new epoch in managed care contracting for lab test services. News of Aetna’s decision to favor Quest Diagnostics Incorporated with a five-year contract as its only national laboratory provider shows the direction this new epo…
LabCorp Uses United as a “Growth Driver”
By Robert Michel | From the Volume XXXI, Number 1 – January 16, 2024 Issue
CEO SUMMARY: In the first six weeks since its exclusive national contract with UnitedHealth became effective, Laboratory Corporation of America has made major gains in several key markets. It has also begun to share the details of its three-phase strategic plan to maximize the leverage it…
New Competitive Forces Alter Market Status Quo
By Robert Michel | From the Volume XXXI, Number 1 – January 16, 2024 Issue
CEO SUMMARY: January was not kind to Quest Diagnostics, as the company disclosed that it was likely to lose all its UnitedHealth business by year end. It also found itself excluded from the Horizon Blue Cross Blue Shield of New Jersey program. By February 1, however, Quest Diagnostics had…
Quest Acknowledges Loss of United Business
By Robert Michel | From the Volume XXXI, Number 1 – January 16, 2024 Issue
CEO SUMMARY: In the boxing world, prize fights between heavyweight contenders always grab the world’s attention. The same is true in the lab industry, where the current fight between the industry’s two heavyweights has the potential to reshape several important aspects of the national…
JVHL Signs a Contract with UnitedHealth Group
By Robert Michel | From the Volume XXXI, Number 1 – January 16, 2024 Issue
CEO SUMMARY: When UnitedHealth Group announced its exclusive national contract with Laboratory Corporation of America, Joint Venture Hospital Laboratories (JVHL) saw opportunity. That’s because LabCorp does not have a significant presence in Michigan. JVHL parlayed its statewide network…
Consumer-Directed Health Plans To Be Healthcare’s Next Wave
By Robert Michel | From the Volume XXXI, Number 1 – January 16, 2024 Issue
“There is an opportunity for laboratories to put strategies in place to benefit from the changes triggered by wider use of CDHPs.” —Paul Mango CEO SUMMARY: It is widely known that growing numbers of employers are turning to consumer-directed…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized